Page 0010

NEWS

NEWS

REPORT

At the annual Advanced Technologies for the Treatment of Diabetes conference

held in February this year, Insulet announced two new agreements that will allow

consumers the freedom to choose their preferred sensor when using the future

Omnipod Horizon™ System. Insulet signed a global commercial agreement with

Dexcom to combine their G6® continuous glucose monitoring (CGM) and their

G7®, once it's available. In addition, Insulet signed a development partnership

with Abbott to combine their next generation Libre sensor.

Insulet (Omnipod), Abbott and Dexcom

of people still injecting with pens in the

UK can do for their GPs is to write their

doses down in a diary for discussion. By

comparison Dexcom is deliberately agile.

Says Sayer, "When we moved on to our

Dexcom G6 sensor, the sixth generation

of our product, we had to totally close

down and get rid of the entire Dexcom

G5 manufacturing platform. That means

making a production line obsolete every

three years, whereas other suppliers

make their production line obsolete every

10-to-15 years, if not more."

The Dexcom G7 is very much on the

horizon. What can we expect that to bring

with it? "With any CGM there are three

key factors that need to be addressed:

accuracy, cost and convenience. A

sensor must perform well, be reliable and

be easy to wear. Dexcom has charted

its own path, starting small but gaining

pace on the back of the acceptance of

its sensor's accuracy and relative ease of

use. "In 2021 we will be bringing forward

our Dexcom G7 platform the accuracy

of which will be the same - Dexcom is

the gold standard for CGM accuracy.

The cost - or value - should improve as

we think the sensor will last longer than

the Dexcom G6, which is recommended

for wear for 10 days. And in terms of

convenience, inserting the sensor will be

even easier and the size even smaller. In

the US they compare it to the size of a

nickel, in the UK you'd compare it to a

rounded 20p coin. It will be a disc, instead

of lozenge-shaped. It's been designed for

being produced at mass. It comes already

inside an insertion device, so the user

does not have to carry around or have

to hand a separate insertion device. In all

we have very high expectations for the

Dexcom G7 and think our customers are

going to love it."

Mr Sayer was wearing a prototype

Dexcom G7 sensor when I met him,

and I can attest to the small size of the

next-generation sensor. We'll keep you

updated as launch of the product comes

into view next year.

www.dexcom.com/gb

People rely on our

sensors for their

health and well-being.

What we've done is

bring data to the fore,

making it accessible

for users to see on

apps, smartphones

and smart watches.

- Kevin Sayer,

President, Dexcom

"

This page: Dexcom's G6 sensor.

Index

  1. Page 0001
  2. Page 0002
  3. Page 0003
  4. Page 0004
  5. Page 0005
  6. Page 0006
  7. Page 0007
  8. Page 0008
  9. Page 0009
  10. Page 0010
  11. Page 0011
  12. Page 0012
  13. Page 0013
  14. Page 0014
  15. Page 0015
  16. Page 0016
  17. Page 0017
  18. Page 0018
  19. Page 0019
  20. Page 0020
  21. Page 0021
  22. Page 0022
  23. Page 0023
  24. Page 0024
  25. Page 0025
  26. Page 0026
  27. Page 0027
  28. Page 0028
  29. Page 0029
  30. Page 0030
  31. Page 0031
  32. Page 0032
  33. Page 0033
  34. Page 0034
  35. Page 0035
  36. Page 0036
  37. Page 0037
  38. Page 0038

Related Issues